Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData Read more
Pharmexcil urges balance between compliance and commerce to safeguard India’s export momentum and ‘Pharmacy of the World’ status Read more
XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer: Phase 3 EMBARK Trial Read more